Swiss drugmaker Roche began a study last year of its experimental drug, RG6237, as a monotherapy in people with high body ...
Caring for COVID patients motivated Molly Berger to prioritize her own health. She made simple diet changes with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback